儿童 COVID-19. 二：发病机制、疾病谱和管理。
COVID-19 in children. II: Pathogenesis, disease spectrum and management.
机构信息
Discipline of Child and Adolescent Health, University of Sydney, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.
NSW Health Pathology-Nepean, Nepean Hospital, Sydney, New South Wales, Australia.
出版信息
J Paediatr Child Health. 2022 Jan;58(1):46-53. doi: 10.1111/jpc.15811. Epub 2021 Oct 25.
Abstract
The global disruption of the COVID-19 pandemic has impacted the life of every child either directly or indirectly. This review explores the pathophysiology, immune response, clinical presentation and treatment of COVID-19 in children, summarising the most up-to-date data including recent developments regarding variants of concern. The acute infection with SARS-CoV-2 is generally mild in children, whilst the post-infectious manifestations, including paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) and 'long COVID' in children, are more complex. Given that most research on COVID-19 has focused on adult cohorts and that clinical manifestations, treatment availability and impacts differ markedly in children, research that specifically examines COVID-19 in children needs to be prioritised.
摘要
COVID-19 大流行的全球蔓延，直接或间接地影响了每一个儿童的生活。本综述探讨了 COVID-19 在儿童中的病理生理学、免疫反应、临床表现和治疗，总结了包括最近关于关注变体的最新数据。SARS-CoV-2 的急性感染在儿童中通常较轻，而感染后表现，包括与 SARS-CoV-2 相关的儿童炎症性多系统综合征（PIMS-TS）和“长 COVID”，则更为复杂。鉴于大多数 COVID-19 研究都集中在成年人群体，而且儿童的临床表现、治疗方法和影响明显不同，因此需要优先研究专门针对儿童 COVID-19 的研究。
相似文献
1
COVID-19 in children. II: Pathogenesis, disease spectrum and management.
J Paediatr Child Health. 2022 Jan;58(1):46-53. doi: 10.1111/jpc.15811. Epub 2021 Oct 25.
2
Correlation of SARS-CoV-2 Serology and Clinical Phenotype Amongst Hospitalised Children in a Tertiary Children's Hospital in India.
J Trop Pediatr. 2021 Jan 29;67(1). doi: 10.1093/tropej/fmab015.
3
Prospective characterisation of SARS-CoV-2 infections among children presenting to tertiary paediatric hospitals across Australia in 2020: a national cohort study.
BMJ Open. 2021 Nov 8;11(11):e054510. doi: 10.1136/bmjopen-2021-054510.
4
Hide and seek in a pandemic: review of SARS-CoV-2 infection and sequelae in children.
Exp Physiol. 2022 Jul;107(7):653-664. doi: 10.1113/EP089399. Epub 2021 Aug 5.
5
Vitamin D status of children with paediatric inflammatory multisystem syndrome temporally associated with severe acute respiratory syndrome coronavirus 2 (PIMS-TS).
Br J Nutr. 2022 Mar 28;127(6):896-903. doi: 10.1017/S0007114521001562. Epub 2021 May 12.
6
Paediatric Inflammatory Multisystem Syndrome: Temporally Associated with SARS-CoV-2 (PIMS-TS): Cardiac Features, Management and Short-Term Outcomes at a UK Tertiary Paediatric Hospital.
Pediatr Cardiol. 2020 Oct;41(7):1391-1401. doi: 10.1007/s00246-020-02391-2. Epub 2020 Jun 12.
7
Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2.
JAMA. 2020 Jul 21;324(3):259-269. doi: 10.1001/jama.2020.10369.
8
Nationwide observational study of paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the Czech Republic.
Eur J Pediatr. 2022 Oct;181(10):3663-3672. doi: 10.1007/s00431-022-04593-7. Epub 2022 Aug 20.
9
Paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): a narrative review and the viewpoint of the Latin American Society of Pediatric Intensive Care (SLACIP) Sepsis Committee.
BMJ Paediatr Open. 2021 Feb 4;5(1):e000894. doi: 10.1136/bmjpo-2020-000894. eCollection 2021.
10
Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study.
Lancet Child Adolesc Health. 2020 Sep;4(9):669-677. doi: 10.1016/S2352-4642(20)30215-7. Epub 2020 Jul 9.
引用本文的文献
1
Psychological distress and COVID-19 vaccine hesitancy among parents of in-school children after the end of the zero-COVID-19 policy: A city-wide survey in South China.
Hum Vaccin Immunother. 2025 Dec;21(1):2538942. doi: 10.1080/21645515.2025.2538942. Epub 2025 Jul 30.
2
Immunogenicity of COVID-19 booster vaccines in children receiving immunosuppressive medications.
Pediatr Res. 2025 Jul 21. doi: 10.1038/s41390-025-04174-y.
3
Analysis of epidemic trend of respiratory pathogens in children after long-term pathogen isolation.
PeerJ. 2025 Jul 16;13:e19710. doi: 10.7717/peerj.19710. eCollection 2025.
4
Duration of COVID-19 symptoms in children: a longitudinal study in a Rio de Janeiro favela, Brazil.
BMJ Open. 2025 Jul 6;15(7):e095622. doi: 10.1136/bmjopen-2024-095622.
5
Prevalence and factors of COVID-19 among children in Hunan, China, following the deregulation of epidemic control: an observational study in epidemiology.
BMJ Open. 2025 Mar 3;15(3):e089651. doi: 10.1136/bmjopen-2024-089651.
6
Evolution of SARS-CoV-2 epidemics in pediatric population in Liguria (North-west Italy) from March 2020 to December 2022: what could we have learned?
J Prev Med Hyg. 2025 Jan 31;65(4):E483-E490. doi: 10.15167/2421-4248/jpmh2024.65.4.3348. eCollection 2024 Dec.
7
SARS-CoV-2 Infection Among Children in Rondônia, Western Brazilian Amazon: SARS-CoV-2 Among Children in Rondônia.
Adv Virol. 2025 Feb 17;2025:6655790. doi: 10.1155/av/6655790. eCollection 2025.
8
Effect of nirmatrelvir/ritonavir (Paxlovid) on hospitalization among adults with COVID-19: An electronic health record-based target trial emulation from N3C.
PLoS Med. 2025 Jan 17;22(1):e1004493. doi: 10.1371/journal.pmed.1004493. eCollection 2025 Jan.
9
Lights and Shadows of Long COVID: Are Latent Infections the Real Hidden Enemy?
J Clin Med. 2024 Nov 25;13(23):7124. doi: 10.3390/jcm13237124.
10
PaedVacCOVID - safety of the BNT162b2 vaccine against the SARS-CoV-2 in children with and without comorbidities aged 5 to 11 years.
Infection. 2025 Apr;53(2):615-624. doi: 10.1007/s15010-024-02427-2. Epub 2024 Nov 11.
本文引用的文献
1
Care for adults with COVID-19: living guidelines from the National COVID-19 Clinical Evidence Taskforce.
Med J Aust. 2022 Oct 3;217(7):368-378. doi: 10.5694/mja2.51718.
2
How Common is Long COVID in Children and Adolescents?
Pediatr Infect Dis J. 2021 Dec 1;40(12):e482-e487. doi: 10.1097/INF.0000000000003328.
3
Understanding long COVID: a modern medical challenge.
Lancet. 2021 Aug 28;398(10302):725. doi: 10.1016/S0140-6736(21)01900-0.
4
Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study.
Lancet Oncol. 2021 Oct;22(10):1416-1426. doi: 10.1016/S1470-2045(21)00454-X. Epub 2021 Aug 26.
5
Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children.
Nat Biotechnol. 2022 Mar;40(3):319-324. doi: 10.1038/s41587-021-01037-9. Epub 2021 Aug 18.
6
Rapid Increase in Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - Mesa County, Colorado, April-June 2021.
MMWR Morb Mortal Wkly Rep. 2021 Aug 13;70(32):1084-1087. doi: 10.15585/mmwr.mm7032e2.
7
Vaccines for COVID-19: Where do we stand in 2021?
Paediatr Respir Rev. 2021 Sep;39:22-31. doi: 10.1016/j.prrv.2021.07.001. Epub 2021 Jul 12.
8
Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2.
Lancet Child Adolesc Health. 2021 Oct;5(10):708-718. doi: 10.1016/S2352-4642(21)00198-X. Epub 2021 Aug 3.
9
Association between HLA genotypes and COVID-19 susceptibility, severity and progression: a comprehensive review of the literature.
Eur J Med Res. 2021 Aug 3;26(1):84. doi: 10.1186/s40001-021-00563-1.
10
Cardiac Manifestations in COVID-19 Patients: A Focus on the Pediatric Population.
Can J Infect Dis Med Microbiol. 2021 Jul 16;2021:5518979. doi: 10.1155/2021/5518979. eCollection 2021.
Zotero 插件